New York Mets second baseman Robinson Cano has tested positive for a performance-enhancing drug and will be suspended for the entire 2021 season, per Jeff Passan. Cano was due a $24 million salary in 2021 but will forfeit the entire amount. He tested positive for the steroid Stanozolol, according to Anthony DiComo.
Cano was previously suspended in 2018, missing 80 games after testing positive for a diuretic called furosemide. Following the 2018 season, the Mariners traded Cano to the Mets and he is signed through the 2023 season. He played in 49 games this past season, finishing with a slash line of .316/.352/.544. This followed playing 107 games in 2019 and finishing with a line of .256/.307/.428.